EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The role of genomic‐informed risk assessments in predicting dementia outcomes

Shea J Andrews iD, Paulina Tolosa-Tort iD, Caroline Jonson, Brian Fulton-Howard, Alan E Renton, Jennifer S Yokoyama, Kristine Yaffe, Alzheimer's Disease Neuroimaging Initiative

Alzheimer's & Dementia · 2025-11 · 21 (11)

DOI: 10.1002/alz.70826 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 21.11.2025. Verfasst von Shea J Andrews und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Dementia, Genomics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION By integrating genetic and clinical risk factors into genomic‐informed dementia risk reports, healthcare providers can offer patients detailed risk profiles to facilitate understanding of individual risk and support the implementation of personalized strategies for promoting brain health. METHODS We constructed an additive score comprising the modified Cardiovascular Risk Factors, Aging, and Incidence of Dementia Risk Score (mCAIDE), family history of dementia , apolipoprotein E (APOE) genotype, and an Alzheimer's disease (AD) polygenic risk score in National Alzheimer's Coordinating Center (NACC) and Alzheimer's Disease Neuroimaging Iniative (ADNI), and assessed its association with progression to all‐cause dementia. RESULTS A total of 81% of participants had at least one high‐risk indicator for dementia, with each additional risk indicator linked to a 34% increase in the hazard of dementia onset. DISCUSSION We found that most participants in memory and aging clinics had at least one high‐risk indicator for dementia. Furthermore, we observed a dose‐response relationship where a greater number of risk indicators was associated with an increased risk of incident dementia. Highlights Compiled genomic‐informed dementia risk report of genetic and clinical risk factors. Most memory clinic patients have at least one high‐risk indicator for dementia. A higher risk indicator burden is associated with a greater dementia risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DementiaGenomicsHumansMaleFemaleRisk AssessmentAgedApolipoproteins ERisk FactorsDisease ProgressionAlzheimer DiseaseAged, 80 and overGenetic Predisposition to DiseaseMiddle Aged

Stichwörter der Autor:innen

dementia risk scoresgenomic‐informed risk assessmentspolygenic risk scores

Substanzen

Apolipoproteins E

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA.
  • Memory and Aging Center, Department of Neurology, University of California, San Francisco, California, USA.
  • Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, Maryland, USA.
  • DataTecnica LLC, Washington, District of Columbia, USA.
  • Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.

ORCID-Profile: Shea J Andrews, Paulina Tolosa-Tort

Förderung

  • NIA NIH HHS
  • NHLBI NIH HHS
  • NINDS NIH HHS
  • NHGRI NIH HHS
  • NIH HHS
  • Intramural NIH HHS
  • HHS
  • Wellcome Trust

Zitieren

APA

Andrews, S. J., Tolosa-Tort, P., Jonson, C., Fulton-Howard, B., Renton, A. E., Yokoyama, J. S., Yaffe, K., & Alzheimer's Disease Neuroimaging Initiative (2025). The role of genomic‐informed risk assessments in predicting dementia outcomes. Alzheimer's & Dementia, 21(11). https://doi.org/10.1002/alz.70826

Vancouver

Andrews SJ, Tolosa-Tort P, Jonson C, Fulton-Howard B, Renton AE, Yokoyama JS, et al. The role of genomic‐informed risk assessments in predicting dementia outcomes. Alzheimer's & Dementia. 2025;21(11). doi:10.1002/alz.70826

BibTeX
@article{Andrews2025,
  author = {Andrews, Shea J and Tolosa-Tort, Paulina and Jonson, Caroline and Fulton-Howard, Brian and Renton, Alan E and Yokoyama, Jennifer S and Yaffe, Kristine and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
  title = {The role of genomic‐informed risk assessments in predicting dementia outcomes},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {11},
  doi = {10.1002/alz.70826}
}
Kostenlos starten →